Related Experiment Video
Updated: Sep 8, 2025

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
Lipid mediated formation of antiparallel aggregates in cerebral amyloid angiopathy
Ana Pacheco de Oliveira1, Divya Baghel1, Brooke Holcombe1
1Department of Chemistry and Biochemistry, The University of Alabama, Tuscaloosa, AL, 35401, USA.
Insights
Cerebral amyloid angiopathy (CAA) involves amyloid-β (Aβ) buildup in brain vessels. This study reveals increasing antiparallel β-sheet structures in Aβ deposits with CAA severity, linked to lipids and potential neurotoxicity.
Area of Science:
- Neuroscience
- Biochemistry
- Medical Imaging
Background:
- Cerebral amyloid angiopathy (CAA) is a cerebrovascular disorder characterized by amyloid-β (Aβ) deposition in brain blood vessels, often leading to hemorrhage and stroke.
- While sharing amyloid-β pathology with Alzheimer's disease (AD), the precise structural forms and chemical associations of Aβ in CAA remain unclear.
- Existing methods may miss the heterogeneity and polymorphic nature of vascular amyloid aggregates.
Purpose of the Study:
- To investigate the chemical structure and heterogeneity of vascular amyloid aggregates in human brain tissues across different stages of CAA.
- To elucidate the structural variations of amyloid-β (Aβ) deposits and their relationship with disease progression and co-localized molecules.
Main Methods:
- Utilized sub-diffraction, label-free optical photothermal infrared (O-PTIR) spectroscopic imaging to analyze vascular amyloid aggregates directly in human brain tissue.
- Employed nanoscale AFM-IR spectroscopy to validate ex-vivo findings and study in-vitro Aβ aggregation with lipids.
- Examined amyloid-β (Aβ) structural distributions in relation to disease severity and lipid co-localization.
Main Results:
- Demonstrated a progressive increase in β-sheet content within vascular Aβ deposits correlating with CAA severity.
- Identified a significant abundance of antiparallel β-sheet structures, particularly in moderate to severe CAA cases.
- Observed a strong correlation between antiparallel Aβ structures and co-localized lipids, suggesting a lipid-mediated aggregation mechanism.
Conclusions:
- The study reveals distinct structural polymorphs of amyloid-β (Aβ) in cerebral amyloid angiopathy (CAA), including antiparallel β-sheets, which increase with disease severity.
- Lipid co-localization with antiparallel Aβ structures suggests a lipid-driven aggregation pathway in CAA.
- These findings offer critical insights into Aβ aggregate structures in CAA, potentially explaining alternate neurotoxic mechanisms beyond traditional fibril models.
Abstract:
Cerebral amyloid angiopathy (CAA) is a cerebrovascular disorder marked by amyloid-β (Aβ) deposition in blood vessel walls, leading to hemorrhage and recurring stroke. Despite significant overlap with Alzheimer's disease (AD) through shared Aβ pathology, the specific structural characteristics of Aβ aggregates in CAA and their variations between stages of disease severity are yet to be fully understood. Traditional approaches relying on brain-derived fibrils can potentially overlook the polymorphic heterogeneity and chemical associations within vascular amyloids. This study utilizes sub-diffraction, label-free optical photothermal infrared (O-PTIR) spectroscopic imaging to directly probe the chemical structure and heterogeneity of vascular amyloid aggregates within human brain tissues across different CAA stages. Our results demonstrate a clear increase in β-sheet content within vascular Aβ deposits corresponding to disease progression. Crucially, we identify a significant presence of antiparallel β-sheet structures, particularly prevalent in moderate/severe CAA. The abundance of antiparallel structures correlates strongly with co-localized lipids, implicating a lipid-mediated aggregation mechanism. We substantiate the ex-vivo observations using nanoscale AFM-IR spectroscopy and demonstrate that Aβ40 aggregated in-vitro with brain-derived lipids adopts antiparallel structural distributions mirroring those found in CAA vascular lesions. This work provides critical insights into the structural distributions of Aβ aggregates in CAA, highlighting the presence of polymorphs typically associated with transient intermediates, which may lead to alternate mechanisms for neurotoxicity.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

